TotalMarketCap

BGM Group

BGMNasdaq ChinaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$118.852 M

$8.90 +2.89%

Close of 6 Nov 2026

As of 6 Nov 2026, BGM Group (BGM) has a market capitalization of $118.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$37.9M

#2804 by revenue

Earnings

-$19.9M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #278Akebia TherapeuticsAKBA$121.3M
  2. #279Journey MedicalDERM$121.2M
  3. #280BGM GroupBGM$118.9M
  4. #281NkartaNKTX$114.2M
  5. #282Foghorn TherapeuticsFHTX$113.1M

What if BGM Group were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,114,470

Per share 237,581× higher

Bitcoin $1.53T

$114,410.31

Per share 12,855× higher

Apple $5.02T

$375,598.36

Per share 42,202× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for BGM Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.